Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: Differential signalling via Akt and ERK

Cell Biochemistry and Function

Volumn 30, Issue 4, 2012, Pages 297-302

  Zhang, Wei ^a   Shen, Xing ^a   Wan, Chao ^b   Zhao, Qiang ^a   Zhang, Lianfang ^a   Zhou, Qi ^a   Deng, Lianfu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

IGF 1; IGF 1R; Insulin; IR; Osteoblast; Osteocalcin

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 84862832214     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2801     Document Type: Article

References (19)

1. Nef S, Parada LF. Hormones in male sexual development. Genes Dev 2000; 14(24): 3075-86.
2. Entingh-Pearsall A, Kahn CR. Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I. J Biol Chem 2004; 279(36): 38016-24.
3. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7(2): 85-96.
4. Thrailkill KM, Lumpkin CK, Jr, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005; 289(5): E735-45.
5. Laron Z, Klinger B, Silbergeld A. Patients with Laron syndrome have Osteopenia/Osteoporosis. J Bone Miner Res 1999; 14(1): 156-7.
6. Psiachou H, Mitton S, Alaghband-Zadeh J, Hone J, Taylor SI, Sinclair L. Leprechaunism and homozygous nonsense mutation in the insulin receptor gene. Lancet 1993; 342(8876): 924.
7. Wertheimer E, Lu SP, Backeljauw PF, Davenport ML, Taylor SI. Homozygous deletion of the human insulin receptor gene results in leprechaunism. Nat Genet 1993; 5(1): 71-3.
8. Evans PR. Leprechaunism. Arch Dis Child 1955; 30(154): 479-83.
9. Salmon MA, Webb JN. Dystrophic Changes Associated with Leprechaunism in a Male Infant. Arch Dis Child 1963; 38: 530-5.
10. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 2002; 277(46): 44005-12.
11. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 2000; 141(7): 2674-82.
12. Jiang J, Lichtler AC, Gronowicz GA, Adams DJ, Clark SH, Rosen CJ, et al. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 2006; 39(3): 494-504.
13. Fulzele K, DiGirolamo DJ, Liu Z, Xu J, Messina JL, Clemens TL. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem 2007; 282(35): 25649-58.
14. Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010; 142(2): 309-19.
15. Balcerzak M, Hamade E, Zhang L, Pikula S, Azzar G, Radisson J, et al. The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochim Pol 2003; 50(4): 1019-38.
16. Zaidi M. Skeletal remodeling in health and disease. Nat Med 2007; 13(7): 791-801.
17. Birnbaum RS, Bowsher RR, Wiren KM. Changes in IGF-I and -II expression and secretion during the proliferation and differentiation of normal rat osteoblasts. J Endocrinol 1995; 144(2): 251-9.
18. Komori T. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 2005; 95(3): 445-53.
19. Fowlkes JL, Bunn RC, Liu L, Wahl EC, Coleman HN, Cockrell GE, et al. Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus. Endocrinology 2008; 149(4): 1697-704.